BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20740484)

  • 1. Structural refinement of the hERG1 pore and voltage-sensing domains with ROSETTA-membrane and molecular dynamics simulations.
    Subbotina J; Yarov-Yarovoy V; Lees-Miller J; Durdagi S; Guo J; Duff HJ; Noskov SY
    Proteins; 2010 Nov; 78(14):2922-34. PubMed ID: 20740484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of H562 in the S5 helix with T618 and S621 in the pore helix are important determinants of hERG1 potassium channel structure and function.
    Lees-Miller JP; Subbotina JO; Guo J; Yarov-Yarovoy V; Noskov SY; Duff HJ
    Biophys J; 2009 May; 96(9):3600-10. PubMed ID: 19413965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic interactions between the voltage sensor and pore mediate inactivation in Kv11.1 channels.
    Perry MD; Wong S; Ng CA; Vandenberg JI
    J Gen Physiol; 2013 Sep; 142(3):275-88. PubMed ID: 23980196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators.
    Guo J; Durdagi S; Changalov M; Perissinotti LL; Hargreaves JM; Back TG; Noskov SY; Duff HJ
    PLoS One; 2014; 9(9):e105553. PubMed ID: 25191697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K+ conductance.
    Perry M; Sachse FB; Abbruzzese J; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20075-80. PubMed ID: 19892732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of open, closed, and open-inactivated states of the hERG1 channel: structural mechanisms of the state-dependent drug binding.
    Durdagi S; Deshpande S; Duff HJ; Noskov SY
    J Chem Inf Model; 2012 Oct; 52(10):2760-74. PubMed ID: 22989185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pore-Lipid Interface: Role of Amino-Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain.
    Perissinotti L; Guo J; Kudaibergenova M; Lees-Miller J; Ol'khovich M; Sharapova A; Perlovich GL; Muruve DA; Gerull B; Noskov SY; Duff HJ
    Mol Pharmacol; 2019 Aug; 96(2):259-271. PubMed ID: 31182542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
    Perry M; Sachse FB; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between voltage sensor and pore domains in a hERG K+ channel model from molecular simulations and the effects of a voltage sensor mutation.
    Colenso CK; Sessions RB; Zhang YH; Hancox JC; Dempsey CE
    J Chem Inf Model; 2013 Jun; 53(6):1358-70. PubMed ID: 23672495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
    Durdagi S; Duff HJ; Noskov SY
    J Chem Inf Model; 2011 Feb; 51(2):463-74. PubMed ID: 21241063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid regulation of hERG1 channel function.
    Miranda WE; Guo J; Mesa-Galloso H; Corradi V; Lees-Miller JP; Tieleman DP; Duff HJ; Noskov SY
    Nat Commun; 2021 Mar; 12(1):1409. PubMed ID: 33658490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations suggest possible activation and deactivation pathways in the hERG channel.
    Costa F; Guardiani C; Giacomello A
    Commun Biol; 2022 Feb; 5(1):165. PubMed ID: 35210539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.
    Perry M; Sanguinetti MC
    Mol Pharmacol; 2008 Apr; 73(4):1044-51. PubMed ID: 18162604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voltage-dependent activation in EAG channels follows a ligand-receptor rather than a mechanical-lever mechanism.
    Malak OA; Gluhov GS; Grizel AV; Kudryashova KS; Sokolova OS; Loussouarn G
    J Biol Chem; 2019 Apr; 294(16):6506-6521. PubMed ID: 30808709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The S4-S5 linker directly couples voltage sensor movement to the activation gate in the human ether-a'-go-go-related gene (hERG) K+ channel.
    Ferrer T; Rupp J; Piper DR; Tristani-Firouzi M
    J Biol Chem; 2006 May; 281(18):12858-64. PubMed ID: 16524878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mechanism of voltage-dependent gating exposed by K
    Tomczak AP; Fernández-Trillo J; Bharill S; Papp F; Panyi G; Stühmer W; Isacoff EY; Pardo LA
    J Gen Physiol; 2017 May; 149(5):577-593. PubMed ID: 28360219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First universal pharmacophore model for hERG1 K
    Durdagi S; Erol I; Salmas RE; Patterson M; Noskov SY
    J Mol Graph Model; 2017 Jun; 74():153-170. PubMed ID: 28499268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3.
    Gardner A; Wu W; Thomson S; Zangerl-Plessl EM; Stary-Weinzinger A; Sanguinetti MC
    Mol Pharmacol; 2017 Oct; 92(4):437-450. PubMed ID: 28705808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Linker Accounts for Differential Sensitivity of ERG1 and ERG2 K+ Channels to RPR260243-Induced Slow Deactivation.
    Gardner A; Sanguinetti MC
    Mol Pharmacol; 2015 Jul; 88(1):19-28. PubMed ID: 25888115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neutral, hydrophobic isoleucine at position I521 in the extracellular S4 domain of hERG contributes to channel gating equilibrium.
    Dou Y; Goodchild SJ; Velde RV; Wu Y; Fedida D
    Am J Physiol Cell Physiol; 2013 Aug; 305(4):C468-78. PubMed ID: 23761630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.